InsidersTradesSigma
Explore the detailed record of transactions filed by Sander Dale A., Chief Financial Officer. Officer active across 1 company, notably Humacyte, Inc.. Aggregated, 1 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 17 May 2022. The latest transaction was disclosed on 17 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Dale A. Sander is the CFO and Chief Corp. Deve. Off. at Humacyte, Inc. He manages the company's finances while overseeing strategic development initiatives.